The mechanistic hypothesis: Semaglutide activates GLP-1R, appetite suppression, glycemic control Cagrilintide activates amylin receptors, appetite suppression via the area postrema, slowing of gastric evacuation Two independent mechanisms of appetite suppression a supra-additive effect In Phase 1b and Phase 2 trials the combination showed a stronger effect than either component alone : Semaglutide alone: 14.9 % (STEP-1) Cagrilintide alone (Phase 2): 10.8 % CagriSema combination (Phase 2): 15.6 % CagriSema Phase 3 (REDEFINE 1): 25.3 % CagriSema thus becomes the largest body-weight signal reported in the published incretin literature to date , stronger than Tirzepatide (22.5 % in SURMOUNT-1) and comparable to Retatrutide
This is the trade pack of 50 ampoules , formatted for those who use B-complex ampoules on a regular schedule recommended by a healthcare professional, and want a larger pack at trade pricing
Lock in NAD+ package savings Most patients run a series
Copper tripeptide (GHK-Cu) is a naturally occurring tripeptide complex consisting of glycyl-L-histidyl-L-lysine bound to a copper ion
Researchers have studied its effects on tissue repair, angiogenesis, and nitric oxide signaling in preclinical models for more than two decades